|
CELF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.96900001753409E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67396999999347E-05 |
| Normal-vs-Stage2 |
1.384520E-04 |
| Normal-vs-Stage3 |
1.54900003934699E-09 |
| Normal-vs-Stage4 |
3.35550000007956E-08 |
| Stage1-vs-Stage2 |
3.488400E-01 |
| Stage1-vs-Stage3 |
3.396800E-03 |
| Stage1-vs-Stage4 |
1.488270E-02 |
| Stage2-vs-Stage3 |
2.436400E-01 |
| Stage2-vs-Stage4 |
3.181200E-01 |
| Stage3-vs-Stage4 |
9.306200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.37609995515464E-09 |
| Normal-vs-AfricanAmerican |
2.43929999999004E-05 |
| Normal-vs-Asian |
5.111800E-01 |
| Caucasian-vs-AfricanAmerican |
6.020800E-01 |
| Caucasian-vs-Asian |
1.604140E-02 |
| AfricanAmerican-vs-Asian |
2.229800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.98819890843083E-11 |
| Normal-vs-Female |
2.022000E-04 |
| Male-vs-Female |
6.357800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.843500E-04 |
| Normal-vs-Age(41-60Yrs) |
3.2415999999813E-06 |
| Normal-vs-Age(61-80Yrs) |
5.02230002030757E-09 |
| Normal-vs-Age(81-100Yrs) |
1.357830E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.032800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.819600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.814800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.144400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.366970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.151800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.275200E-01 |
| Normal-vs-Grade 2 |
1.58335000000065E-05 |
| Normal-vs-Grade 3 |
9.74070046844133E-10 |
| Normal-vs-Grade 4 |
1.34040001320557E-10 |
| Grade 1-vs-Grade 2 |
3.717200E-03 |
| Grade 1-vs-Grade 3 |
1.751640E-04 |
| Grade 1-vs-Grade 4 |
1.52855999999701E-05 |
| Grade 2-vs-Grade 3 |
2.300500E-02 |
| Grade 2-vs-Grade 4 |
1.175130E-03 |
| Grade 3-vs-Grade 4 |
1.042630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.824160E-03 |
| Normal-vs-ccB subtype |
2.56550003463474E-10 |
| ccA subtype-vs-ccB subtype |
2.3689000000493E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.18699999618732E-08 |
| Normal-vs-N1 |
2.832600E-04 |
| N0-vs-N1 |
3.629000E-01 |
|
|
